by In2Pharma | Apr 15, 2021 | News
Belgium The question was raised by some of the members whether it is needed to decommission commercial packages during (re)-labelling to medical samples, Medical Need Program (MNP) products and Investigational Medicinal Products (IMP). After verification in the...
